Sana Biotechnology Inc (SANA)
10.44
+0.66
(+6.75%)
USD |
NASDAQ |
May 03, 16:00
10.44
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Price to Book Value: 8.005 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 8.005 |
| May 02, 2024 | 7.499 |
| May 01, 2024 | 7.384 |
| April 30, 2024 | 6.901 |
| April 29, 2024 | 6.962 |
| April 26, 2024 | 6.686 |
| April 25, 2024 | 6.517 |
| April 24, 2024 | 6.579 |
| April 23, 2024 | 6.203 |
| April 22, 2024 | 6.080 |
| April 19, 2024 | 5.835 |
| April 18, 2024 | 5.927 |
| April 17, 2024 | 6.333 |
| April 16, 2024 | 6.448 |
| April 15, 2024 | 6.556 |
| April 12, 2024 | 6.870 |
| April 11, 2024 | 7.177 |
| April 10, 2024 | 6.901 |
| April 09, 2024 | 7.162 |
| April 08, 2024 | 6.970 |
| April 05, 2024 | 6.908 |
| April 04, 2024 | 6.525 |
| April 03, 2024 | 7.024 |
| April 02, 2024 | 6.763 |
| April 01, 2024 | 7.760 |
| Date | Value |
|---|---|
| March 28, 2024 | 7.668 |
| March 27, 2024 | 7.668 |
| March 26, 2024 | 7.254 |
| March 25, 2024 | 6.970 |
| March 22, 2024 | 7.016 |
| March 21, 2024 | 7.016 |
| March 20, 2024 | 6.862 |
| March 19, 2024 | 6.632 |
| March 18, 2024 | 6.832 |
| March 15, 2024 | 6.809 |
| March 14, 2024 | 6.939 |
| March 13, 2024 | 7.553 |
| March 12, 2024 | 7.108 |
| March 11, 2024 | 7.284 |
| March 08, 2024 | 7.284 |
| March 07, 2024 | 7.346 |
| March 06, 2024 | 7.461 |
| March 05, 2024 | 7.522 |
| March 04, 2024 | 7.254 |
| March 01, 2024 | 8.641 |
| February 29, 2024 | 7.698 |
| February 28, 2024 | 8.181 |
| February 27, 2024 | 7.622 |
| February 26, 2024 | 6.479 |
| February 23, 2024 | 6.353 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.075
Minimum
Dec 27 2022
8.641
Maximum
Mar 01 2024
3.094
Average
2.498
Median
Apr 19 2023
Price to Book Value Benchmarks
| Rocket Pharmaceuticals Inc | 4.312 |
| Solid Biosciences Inc | 3.023 |
| Dyne Therapeutics Inc | 4.767 |
| Taysha Gene Therapies Inc | 6.414 |
| Tenaya Therapeutics Inc | 2.636 |
Price to Book Value Related Metrics
| Price | 10.44 |
| Earnings Yield | -14.08% |
| Market Cap | 2.301B |